Cargando…
Novel Microbial-Based Immunotherapy Approach for Crohn's Disease
Background: Current Crohn's disease (CD) therapies focus on suppressing immune function and come with consequent risk, such as infection and cancer. Notwithstanding, most CD patients still experience disease progression. There is a need for new CD treatment strategies that offer better health o...
Autores principales: | Sutcliffe, Simon, Kalyan, Shirin, Pankovich, Jim, Chen, Jenny M. H., Gluck, Rashieda, Thompson, Darby, Bosiljcic, Momir, Bazett, Mark, Fedorak, Richard N., Panaccione, Remo, Axler, Jeffrey, Marshall, John K., Mullins, David W., Kabakchiev, Boyko, McGovern, Dermot P. B., Jang, Julie, Coldman, Andrew, Vandermeirsch, Gillian, Bressler, Brian, Gunn, Hal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659126/ https://www.ncbi.nlm.nih.gov/pubmed/31380382 http://dx.doi.org/10.3389/fmed.2019.00170 |
Ejemplares similares
-
Immune Stimulation Using a Gut Microbe-Based Immunotherapy Reduces Disease Pathology and Improves Barrier Function in Ulcerative Colitis
por: Sham, Ho Pan, et al.
Publicado: (2018) -
Harnessing innate lung anti-cancer effector functions with a novel bacterial-derived immunotherapy
por: Bazett, Mark, et al.
Publicado: (2017) -
A novel microbe-based treatment that attenuates the inflammatory profile in a mouse model of allergic airway disease
por: Bazett, Mark, et al.
Publicado: (2016) -
Attenuating immune pathology using a microbial-based intervention in a mouse model of cigarette smoke-induced lung inflammation
por: Bazett, Mark, et al.
Publicado: (2017) -
Distinct inactivated bacterial-based immune modulators vary in their therapeutic efficacies for treating disease based on the organ site of pathology
por: Kalyan, Shirin, et al.
Publicado: (2020)